Aurinia Pharma Q1 2023 Earnings Preview
- Aurinia Pharma (NASDAQ:AUPH) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open.
- The consensus EPS Estimate is -$0.22 and the consensus Revenue Estimate is $28.12M (+30.0% Y/Y).
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 2 downward.